News from the catapult network

News headlines from across the Catapult Network. For comprehensive news updates, please explore our Politics Home webpage or visit individual Catapult websites

Upwards arrow in orange and pink against dark backround
Catapult Network
NEWS
Listen to our Supercharging Innovation podcast series
This latest series explores how the UK must break down barriers to solve national and global challenges and how this can be realised through the power of science, innovation and technology. You’ll be hearing from our expert Catapult panellists and an array of very special guests including industrialists, academics, politicians and thought leaders.
Read more
Compound Semiconductor Applications
alt=
News
Compound Semiconductor Applications Catapult wins funding to develop prototype of advanced quantum communication technology
Compound Semiconductor Applications Catapult is part of a consortium that is one of the winners of the Quantum Missions pilot competition, securing a share of £12m of funding from Innovate UK. The collaboration brings together Vector Photonics, Phlux Technology, and the University of Bristol, alongside the Catapult’s expertise. The initiative aims to accelerate the development of quantum computing (QC) and quantum networks (QN) by overcoming barriers to commercialisation – leveraging capabilities already proven by the Catapult’s earlier feasibility study, QUDITS, delivered in 2024.
Read more
Compound Semiconductor Applications
News
Compound Semiconductor Applications Catapult wins funding to develop prototype of advanced quantum communication technology
Compound Semiconductor Applications Catapult is part of a consortium that is one of the winners of the Quantum Missions pilot competition, securing a share of £12m of funding from Innovate UK. The collaboration brings together Vector Photonics, Phlux Technology, and the University of Bristol, alongside the Catapult’s expertise. The initiative aims to accelerate the development of quantum computing (QC) and quantum networks (QN) by overcoming barriers to commercialisation – leveraging capabilities already proven by the Catapult’s earlier feasibility study, QUDITS, delivered in 2024.
Read more
Cell and Gene Therapy
Someone working at a laptop with a mug in front of it
News
70% increase in Phase I advanced therapy clinical trials in the UK in 2024
The number of ongoing advanced therapy clinical trials in the UK reached 187 in 2024, an increase of 7% compared from the previous year. This includes a significant approximate increase of 70% in the number of Phase I trials, which grew from 24 to 41. The data is presented in the Cell and Gene Therapy Catapult’s UK 2024 Advanced Therapy Medicinal Product (ATMP) Clinical Trials Database.
Read more
Offshore Renewable Energy
News
A dozen North East businesses chosen for award-winning offshore renewables supply chain programme
Twelve businesses in the North East of Scotland targeting success in the offshore renewable energy market have been selected for the award-winning Fit For Offshore Renewables (F4OR) supply chain support programme. The programme is open to companies looking to break into the offshore renewable energy sector, scale up an existing presence in the industry, or make the transition to renewables from other sectors, such as oil and gas. F4OR is delivered by the Offshore Renewable Energy Catapult, and has supported more than 150 companies over the last five years who have, on average, experienced an increase in turnover of 28% as a result of securing new contracts and many have gone on to become market-leading suppliers to the offshore wind sector.
Read more
Medicines Discovery
alt=
News
Medicines Discovery Catapult achieves ISO 45001 health and safety standard
Medicines Discovery Catapult has been awarded ISO 45001, an international standard for occupational health and safety. The standard is the world’s first international standard for occupational health and safety. Independently certified, it provides a framework to increase safety, reduce workplace risks and enhance health and wellbeing in the workplace.
Read more
Cell and Gene Therapy
alt=
News
Network established to identify opportunities for regulation to support innovation within advanced therapies
A new network will foster collaboration among regulators, industry, and researchers to ensure there is a world-leading regulatory environment in the UK for advanced therapies that supports companies in the development, trial, and launch of these innovative treatments. Cell and Gene Therapy Catapult, an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, and the Birmingham Health Partners Centre for Regulatory Science and Innovation (CRSI) established the network with funding from Innovate UK and support from the MHRA.
Read more
Catapult Network
alt=
News
Exploring a Catapult legacy with Stuart Martin
We sat down with Stuart Martin, CEO of Satellite Applications Catapult and founding member of the Catapult network, to talk about the mark he’s left on the UK space sector and the evolving mission of Catapults over his 10-years at the helm.
Read more
Catapult Network
News
Exploring a Catapult legacy with Stuart Martin
We sat down with Stuart Martin, CEO of Satellite Applications Catapult and founding member of the Catapult network, to talk about the mark he’s left on the UK space sector and the evolving mission of Catapults over his 10-years at the helm.
Read more